Camille M. Fung, MD

Languages Spoken: Cantonese, English

Camille Fung, MD is an Assistant Professor in the Division of Neonatology, Department of Pediatrics at the University of Utah, School of Medicine. In addition to caring for sick newborns who require intensive care in 3 different NICUs in the Salt Lake valley, she has a basic science research interest in looking at the effects of perinatal insults such as intrauterine growth restriction (IUGR) on hippocampal neuronal development. This is important because IUGR infants are at increased risk for neurocognitive delays particularly affecting learning and memory, functions that are carried out by the hippocampus, but the underlying mechanisms leading to such delays remain elusive. She uses a mouse model of IUGR that she developed, which mimicks human pregnancy-induced hypertension, to study embyronic and postnatal hippocampal neurogenesis and development. In addition to IUGR's effects on the central nervous system, she has collabrations both within and outside of the University of Utah investigating the mechanisms of IUGR-induced retinopathy, metabolic syndrome, necrotizing enterocolitis, and chronic lung disease/pulmonary hypertension. Relating to her basic science interest, she has quality improvement and clinical research interests on neonatal abstinence syndrome (NAS) management. The incidence of NAS has skyrocketed across the U.S., attributed to prescription opioid misuse and abuse. She has worked closely with interdisciplinary teams both at Intermountain and University Healthcare systems to implement a care process model on NAS management. Working with the Utah Department of Health, she is extending this care process model to other healthcare systems across Utah such that we have a standardized practice on all infants suffering from NAS. She is also a principal investigator on a multi-center clinical trial initiated by Stanford University to use ondansetron as a medication to prevent/curb NAS symptoms. Enrollment of mother-infant pairs is ongoing. Lastly, recognizing the misuse and abuse of prescription opioids, the Utah Division of Professional Licensing passed a mandate that all licensed practitioners who have the ability to prescribe opioids to take a 4-hour educational session on responsible prescribing practice. Dr. Fung, working closely with the University CME office, has been the course director who planned and implemented the curriculum entitled, "Opioid use in pregnant mothers and newborns: what obstetricians and pediatricians should know". Both live presentations and now a web-based version of this course can be accessed by all interested practitioners.

Camille Fung, MD is an Assistant Professor in the Division of Neonatology, Department of Pediatrics at the University of Utah, School of Medicine. In addition to caring for sick newborns who require intensive care in 3 different NICUs in the Salt Lake valley, she has a basic science research interest in looking at the effects of perinatal insults such as intrauterine growth restriction (IUGR) on hippocampal neuronal development. This is important because IUGR infants are at increased risk for neurocognitive delays particularly affecting learning and memory, functions that are carried out by the hippocampus, but the underlying mechanisms leading to such delays remain elusive. She uses a mouse model of IUGR that she developed, which mimicks human pregnancy-induced hypertension, to study embyronic and postnatal hippocampal neurogenesis and development. In addition to IUGR's effects on the central nervous system, she has collabrations both within and outside of the University of Utah investigating the mechanisms of IUGR-induced retinopathy, metabolic syndrome, necrotizing enterocolitis, and chronic lung disease/pulmonary hypertension. Relating to her basic science interest, she has quality improvement and clinical research interests on neonatal abstinence syndrome (NAS) management. The incidence of NAS has skyrocketed across the U.S., attributed to prescription opioid misuse and abuse. She has worked closely with interdisciplinary teams both at Intermountain and University Healthcare systems to implement a care process model on NAS management. Working with the Utah Department of Health, she is extending this care process model to other healthcare systems across Utah such that we have a standardized practice on all infants suffering from NAS. She is also a principal investigator on a multi-center clinical trial initiated by Stanford University to use ondansetron as a medication to prevent/curb NAS symptoms. Enrollment of mother-infant pairs is ongoing. Lastly, recognizing the misuse and abuse of prescription opioids, the Utah Division of Professional Licensing passed a mandate that all licensed practitioners who have the ability to prescribe opioids to take a 4-hour educational session on responsible prescribing practice. Dr. Fung, working closely with the University CME office, has been the course director who planned and implemented the curriculum entitled, "Opioid use in pregnant mothers and newborns: what obstetricians and pediatricians should know". Both live presentations and now a web-based version of this course can be accessed by all interested practitioners.